Pharmazie 2013-07-01

Defining the role of MRP-mediated efflux and glutathione in detoxification of oxaliplatin.

C Mohn, H-G Häcker, R A Hilger, M Gütschow, U Jaehde

Index: Pharmazie 68(7) , 622-7, (2013)

Full Text: HTML

Abstract

Albeit platinum complexes are widely used in cancer chemotherapy, their cellular processing has not been completely elucidated so far. In this study the effects of modulating multidrug resistance-associated protein (MRP)-mediated efflux and glutathione (GSH) depletion on the cytotoxicity of oxaliplatin were assessed in a human ileocecal colorectal adenocarcinoma cell line and its oxaliplatin-resistant variant. Upon oxaliplatin exposure, DNA platination was elevated by co-incubation with Gü83, a MRP1 and MRP2 inhibitor, but cytotoxicity was not increased. Addition of oxaliplatin did not alter the cellular GSH content. Following GSH depletion, platinum accumulation was unchanged but cytotoxicity was increased in oxaliplatin-sensitive cells. In conclusion, modulation of MRP-mediated efflux did not affect oxaliplatin cytotoxicity in the investigated cell lines. Intracellular GSH depletion seems to sensitize the cells but does not overcome resistance.

Related Compounds

  • platinum
  • Oxaliplatin
  • Glutathione

Related Articles:

A new deposition method for the preparation of Pt-Pd nanocatalysts on a nafion coated carbon black via the reduction of metallic precursors in a drying process.

2013-05-01

[J. Nanosci. Nanotechnol. 13(5) , 3634-7, (2013)]

Effect of particle size of PtRu nanoparticles embedded in WO3 on electrocatalysis.

2013-05-01

[J. Nanosci. Nanotechnol. 13(5) , 3591-6, (2013)]

Electrolytic removal of ammonia from aqueous phase by Pt/Ti anode.

2013-01-01

[Water Sci. Technol. 67(11) , 2451-7, (2013)]

Disturbance of DNA conformation by the binding of testosterone-based platinum drugs via groove-face and intercalative interactions: a molecular dynamics simulation study.

2013-01-01

[BMC Struct. Biol. 13 , 4, (2013)]

Analysis of failures and clinical outcome of advanced epithelial ovarian cancer in patients with microscopic residual disease at second-look reassessment following primary cytoreductive surgery and first-line platinum-based chemotherapy.

2013-01-01

[Eur. J. Gynaecol. Oncol. 34(3) , 213-7, (2013)]

More Articles...